Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cryoport, Inc.CYRX · Entity 5125 | Chief Digital and Tech Officer | June 10, 2026 | June 12, 2026 |
| Ontrak, Inc.OTRK · Entity 78207 | Director | July 19, 2022 | July 21, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cryoport, Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 109,719 |
Ending reported balance
After 2026-06-11 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-06-10 · Exercise / conversion · Acquired 1,400 · Balance 111,119 Row 2 · 2026-06-10 · Sale · Disposed 1,400 · Balance 109,719 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.20 to $15.26, inclusive. Row 3 · 2026-06-11 · Exercise / conversion · Acquired 33,600 · Balance 143,319 Row 4 · 2026-06-11 · Sale · Disposed 33,600 · Balance 109,719 F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.33 to $14.615, inclusive. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.80 · Expires 2027-06-23 | Direct | 33,600 |
Reported balance
After 2026-06-10 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-06-10 · Exercise / conversion · Disposed 1,400 · Balance 33,600 F3: 1/12 of options vested on the 23rd of each month for twelve months beginning July 23, 2017. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.80 · Expires 2027-06-23 | Direct | 0 |
Reported balance
After 2026-06-11 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-06-11 · Exercise / conversion · Disposed 33,600 · Balance 0 F3: 1/12 of options vested on the 23rd of each month for twelve months beginning July 23, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.20 to $15.26, inclusive.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.33 to $14.615, inclusive.
F3: 1/12 of options vested on the 23rd of each month for twelve months beginning July 23, 2017.
Ontrak, Inc.
Report date July 19, 2022 · Filed July 21, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 10,000 |
Reported balance
After 2022-07-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-07-19 · Grant · Acquired 10,000 · Balance 10,000 F1: These securities were granted to Mr. Zecchini for his services as a member of the Company's Board of Directors. F2: Each restricted stock unit ("RSU") represents the right to receive one share of common stock upon vesting, or, in the complete and sole discretion of the Company, a cash payment equal to the fair market value of one share of common stock for each vested RSU. F3: On July 19, 2022, Mr. Zecchini was granted 10,000 RSU's, subject to Mr. Zecchini's continued Service with the Company through and until the election of directors at the 2022 Annual Meeting of Stockholders. The RSU's vest on the date of the Company's 2022 Annual Meeting of Stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities were granted to Mr. Zecchini for his services as a member of the Company's Board of Directors.
F2: Each restricted stock unit ("RSU") represents the right to receive one share of common stock upon vesting, or, in the complete and sole discretion of the Company, a cash payment equal to the fair market value of one share of common stock for each vested RSU.
F3: On July 19, 2022, Mr. Zecchini was granted 10,000 RSU's, subject to Mr. Zecchini's continued Service with the Company through and until the election of directors at the 2022 Annual Meeting of Stockholders. The RSU's vest on the date of the Company's 2022 Annual Meeting of Stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2026 Filed Jun 12, 2026 22:38 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 33,600 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-26-073630 · tm2617887-1_4seq1.xml · derivative · entry 6 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,600 shares Expires 2027-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/12 of options vested on the 23rd of each month for twelve months beginning July 23, 2017. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 22:38 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 33,600 | $14.47 | $486,239.04 |
DisclosureSEC source: 0001104659-26-073630 · tm2617887-1_4seq1.xml · nonDerivative · entry 4 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,719 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.33 to $14.615, inclusive. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 22:38 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 33,600 | $4.80 | $161,280.00 |
DisclosureSEC source: 0001104659-26-073630 · tm2617887-1_4seq1.xml · nonDerivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:38 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 1,400 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-26-073630 · tm2617887-1_4seq1.xml · derivative · entry 5 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,600 Underlying: Common Stock · 1,400 shares Expires 2027-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/12 of options vested on the 23rd of each month for twelve months beginning July 23, 2017. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:38 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,400 | $15.23 | $21,323.96 |
DisclosureSEC source: 0001104659-26-073630 · tm2617887-1_4seq1.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,719 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.20 to $15.26, inclusive. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:38 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 1,400 | $4.80 | $6,720.00 |
DisclosureSEC source: 0001104659-26-073630 · tm2617887-1_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 00:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 2,014 | $8.00 | $16,112.00 |
DisclosureSEC source: 0001104659-26-029720 · tm269014-4_4seq1.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,719 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 14, 2026 Filed Mar 18, 2026 00:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 63,965 | $0.00 Strike: $8.60 | $0.00 |
DisclosureSEC source: 0001104659-26-029720 · tm269014-4_4seq1.xml · derivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,965 Underlying: Common Stock · 63,965 shares Expires 2033-03-14 F3 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026. Read SEC document |
| March 14, 2026 Filed Mar 18, 2026 00:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 21,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-029720 · tm269014-4_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,733 F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027. F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027. Read SEC document |
| June 10, 2025 Filed Jun 10, 2025 23:28 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $3.07 | $0.00 |
DisclosureSEC source: 0001104659-25-058270 · tm2517578-5_4seq1.xml · derivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48 of options vested on the 19th of each month for forty-eight months beginning August 19, 2015. Read SEC document |
| June 10, 2025 Filed Jun 10, 2025 23:28 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 51,500 | $6.85 | $352,517.50 |
DisclosureSEC source: 0001104659-25-058270 · tm2517578-5_4seq1.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,411 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.9367, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2025 Filed Jun 10, 2025 23:28 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 75,000 | $3.07 | $230,250.00 |
DisclosureSEC source: 0001104659-25-058270 · tm2517578-5_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 23:08 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,140 | $6.29 | $7,172.54 |
DisclosureSEC source: 0001104659-25-025196 · tm259699-4_4seq1.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,911 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 23:08 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $7.05 | $0.00 |
DisclosureSEC source: 0001104659-25-025196 · tm259699-4_4seq1.xml · derivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-03-14 F3 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 23:08 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-025196 · tm259699-4_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,051 F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026. F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026. Read SEC document |
| May 14, 2024 Filed May 15, 2024 23:28 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 3,443 | $13.37 | $46,042.21 |
DisclosureSEC source: 0001104659-24-062114 · tm2414667-1_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,051 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:52 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 20,910 | $0.00 Strike: $16.70 | $0.00 |
DisclosureSEC source: 0001104659-24-036290 · tm249281-6_4seq1.xml · derivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,910 Underlying: Common Stock · 20,910 shares Expires 2031-03-15 F2 · derivative.exercise_date: 1/48 of options vest on the 15th of each month for forty-eight months beginning April 25, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:52 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 10,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-036290 · tm249281-6_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Chief Digital and Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,494 F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025. F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:28 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption (Right to Buy Common Stock) · Derivative | 15,125 | $0.00 Strike: $20.05 | $0.00 |
DisclosureSEC source: 0001104659-23-061522 · tm2316016-5_4seq1.xml · derivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,125 Underlying: Common Stock · 15,125 shares Expires 2030-05-12 F2 · derivative.exercise_date: 1/12th of the options vest on the 12th of the month for twelve months beginning June 12, 2023. Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:28 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 8,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-061522 · tm2316016-5_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,039 F1 · security: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on May 12, 2024, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| July 19, 2022 Filed Jul 21, 2022 17:17 UTC | Ontrak, Inc. OTRK · Entity 78207 | GrantRestricted Stock Unit · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-22-001263 · primary_01.xml · derivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ontrak, Inc. Common Stock · 10,000 shares Expires not disclosed F1 · security: These securities were granted to Mr. Zecchini for his services as a member of the Company's Board of Directors. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the right to receive one share of common stock upon vesting, or, in the complete and sole discretion of the Company, a cash payment equal to the fair market value of one share of common stock for each vested RSU. F3 · derivative.exercise_date: On July 19, 2022, Mr. Zecchini was granted 10,000 RSU's, subject to Mr. Zecchini's continued Service with the Company through and until the election of directors at the 2022 Annual Meeting of Stockholders. The RSU's vest on the date of the Company's 2022 Annual Meeting of Stockholders. F3 · derivative.expiration_date: On July 19, 2022, Mr. Zecchini was granted 10,000 RSU's, subject to Mr. Zecchini's continued Service with the Company through and until the election of directors at the 2022 Annual Meeting of Stockholders. The RSU's vest on the date of the Company's 2022 Annual Meeting of Stockholders. Read SEC document |
| April 30, 2022 Filed May 4, 2022 00:02 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionRestricted Stock Rights · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-055440 · tm2214402-5_4seq1.xml · derivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date. F2 · derivative.expiration_date: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date. Read SEC document |
| April 30, 2022 Filed May 4, 2022 00:02 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 2,708 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-055440 · tm2214402-5_4seq1.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock rights convert to common stock upon vesting on a one-for-one basis and have no expiration date. Read SEC document |
| April 29, 2022 Filed May 4, 2022 00:02 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption (Right to Buy Common Stock) · Derivative | 13,981 | $0.00 Strike: $22.56 | $0.00 |
DisclosureSEC source: 0001104659-22-055440 · tm2214402-5_4seq1.xml · derivative · entry 4 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,981 Underlying: Common Stock · 13,981 shares Expires 2029-04-29 F3 · derivative.exercise_date: 1/12th of the options vest on the 30th of the month for twelve months beginning May 30, 2022. Read SEC document |
| April 29, 2022 Filed May 4, 2022 00:02 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 7,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-055440 · tm2214402-5_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,226 F1 · security: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis. F1 · price: Reflects grant of restricted stock rights that vest in full on April 29, 2023, and upon vesting automatically convert to shares of common stock on a one-for-one basis. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 17:04 UTC | Ontrak, Inc. OTRK · Entity 78207 | GrantOption (right to buy) · Derivative | 49,081 | $0.00 Strike: $8.72 | $0.00 |
DisclosureSEC source: 0001593968-22-000150 · primary_01.xml · derivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,081 Underlying: Ontrak, Inc. Common Stock · 49,081 shares Expires 2027-01-03 F1 · kind: These securities were granted to Mr. Zecchini for his services as a member of the Company's Board of Directors. F2 · derivative.exercise_date: 25% of these options shall vest at the at the end of each quarter beginning January 1, 2022, such that all shares pursuant to the option shall be vested on December 31, 2022. Quarterly vesting of the options will be subject to Mr. Zecchini attending board meetings, unless such absence is excused by the Chairman of the Board. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 19:53 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 5,000 | $0.00 Strike: $3.07 | $0.00 |
DisclosureSEC source: 0001104659-21-089379 · tm2121555-1_4seq1.xml · derivative · entry 4 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 5,000 shares Expires 2025-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F4 · derivative.exercise_date: 1/48 of the options vested on the 7th of each month for forty-eight months beginning on 8/19/2015. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 19:53 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,323 | $63.13 | $83,515.96 |
DisclosureSEC source: 0001104659-21-089379 · tm2121555-1_4seq1.xml · nonDerivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,023 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.04 to $63.19, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 19:53 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 3,677 | $62.60 | $230,169.90 |
DisclosureSEC source: 0001104659-21-089379 · tm2121555-1_4seq1.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,346 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.01 to $62.935, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 19:53 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 5,000 | $3.07 | $15,350.00 |
DisclosureSEC source: 0001104659-21-089379 · tm2121555-1_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 22:31 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 4,167 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001104659-21-080328 · tm2119529-1_4seq1.xml · derivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,167 shares Expires 2025-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F2 · derivative.exercise_date: 1/48th of the options vested on the 7th day of each month for forty-eight months beginning 6/7/2015. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 22:31 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 4,167 | $59.11 | $246,311.37 |
DisclosureSEC source: 0001104659-21-080328 · tm2119529-1_4seq1.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,023 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 22:31 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 4,167 | $7.80 | $32,502.60 |
DisclosureSEC source: 0001104659-21-080328 · tm2119529-1_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:46 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 5,417 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-21-068201 · tm2116712-1_4.xml · derivative · entry 4 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,417 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F4 · derivative.exercise_date: 1/48th of the options vested on the 18th day of each month for forty-eight months beginning 1/18/2015. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:46 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,694 | $52.09 | $88,237.07 |
DisclosureSEC source: 0001104659-21-068201 · tm2116712-1_4.xml · nonDerivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,023 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.73 to $52.63, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:46 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 3,723 | $51.23 | $190,746.79 |
DisclosureSEC source: 0001104659-21-068201 · tm2116712-1_4.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,717 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.73 to $51.72, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:46 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 5,417 | $4.80 | $26,001.60 |
DisclosureSEC source: 0001104659-21-068201 · tm2116712-1_4.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:44 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantRestricted Stock Rights · Derivative | 2,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-063253 · tm2115610d6_4.xml · derivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,708 Underlying: Common Stock · 2,708 shares Expires 2022-04-30 F2 · derivative.exercise_price: Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| April 30, 2021 Filed May 7, 2021 22:44 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantOption to purchase common stock · Derivative | 5,416 | $0.00 Strike: $56.57 | $0.00 |
DisclosureSEC source: 0001104659-21-063253 · tm2115610d6_4.xml · derivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,416 Underlying: Common Stock · 5,416 shares Expires 2028-04-30 F1 · derivative.exercise_date: 1/12th of options vest on the 30th of the month for twelve months beginning May 30, 2021. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 23:24 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 5,417 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-21-048986 · tm2112685-2_4seq1.xml · derivative · entry 4 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,417 Underlying: Common Stock · 5,417 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F4 · derivative.exercise_date: 1/48th of the options vested on the 18th day of each month for the forty-eight months beginning on 1/18/2015. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 23:24 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 3,117 | $52.30 | $163,026.58 |
DisclosureSEC source: 0001104659-21-048986 · tm2112685-2_4seq1.xml · nonDerivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.04 to $52.4997, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this Form 4. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 23:24 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 2,300 | $51.81 | $119,153.11 |
DisclosureSEC source: 0001104659-21-048986 · tm2112685-2_4seq1.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,117 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.23 to $51.96, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 23:24 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 5,417 | $4.80 | $26,001.60 |
DisclosureSEC source: 0001104659-21-048986 · tm2112685-2_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 23:33 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOption to purchase common stock · Derivative | 4,167 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001104659-21-035739 · tm219635d1_4.xml · derivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,167 shares Expires 2024-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F3 · derivative.exercise_date: 1/12 of the options vested on the 24th day of each month for the twelve months beginning on 9/29/2014. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 23:33 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 4,167 | $55.65 | $231,886.88 |
DisclosureSEC source: 0001104659-21-035739 · tm219635d1_4.xml · nonDerivative · entry 2 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,023 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.14 to $55.88, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4. Read SEC document |
| March 11, 2021 Filed Mar 12, 2021 23:33 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 4,167 | $5.04 | $21,001.68 |
DisclosureSEC source: 0001104659-21-035739 · tm219635d1_4.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 20:44 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 208 | $44.11 | $9,174.88 |
DisclosureSEC source: 0001104659-21-000870 · tm211709d2_4seq1.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,023 Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 15:39 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 192 | $47.82 | $9,181.44 |
DisclosureSEC source: 0001104659-20-111501 · tm2032297d1_4.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,815 Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 21:02 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 310 | $29.54 | $9,157.40 |
DisclosureSEC source: 0001104659-20-079776 · tm2023884-2_4.xml · nonDerivative · entry 1 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,623 Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:25 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 8,334 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-20-061753 · tm2019811-1_4.xml · derivative · entry 3 ZECCHINI EDWARD J · CIK 0001587502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,334 shares Expires 2023-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/12 of the options vested on the 13th day of each month for the twelve months beginning on 10/13/2013 and ending on 9/13/2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.